Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Normative brain volume reports may improve differential diagnosis of dementing neurodegenerative diseases in clinical practice.

Hedderich DM, Dieckmeyer M, Andrisan T, Ortner M, Grundl L, Schön S, Suppa P, Finck T, Kreiser K, Zimmer C, Yakushev I, Grimmer T.

Eur Radiol. 2020 Jan 30. doi: 10.1007/s00330-019-06602-0. [Epub ahead of print]

PMID:
32002640
2.

Decreased Vascular Pulsatility in Alzheimer's Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography.

Ortner M, Hauser C, Schmaderer C, Muggenthaler C, Hapfelmeier A, Sorg C, Diehl-Schmid J, Kurz A, Förstl H, Ikenberg B, Kotliar K, Poppert H, Grimmer T.

Neuropsychiatr Dis Treat. 2019 Dec 20;15:3487-3499. doi: 10.2147/NDT.S225754. eCollection 2019.

3.

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.

Ortner M, Drost R, Heddderich D, Goldhardt O, Müller-Sarnowski F, Diehl-Schmid J, Förstl H, Yakushev I, Grimmer T.

BMC Neurol. 2019 Oct 31;19(1):264. doi: 10.1186/s12883-019-1498-9.

4.

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.

Goldhardt O, Warnhoff I, Yakushev I, Begcevic I, Förstl H, Magdolen V, Soosaipillai A, Diamandis E, Alexopoulos P, Grimmer T.

Transl Neurodegener. 2019 Aug 27;8:25. doi: 10.1186/s40035-019-0168-6. eCollection 2019.

5.

Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.

Altomare D, Ferrari C, Caroli A, Galluzzi S, Prestia A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo ILH, Grimmer T, Redolfi A, Nordberg A, Scheltens P, Drzezga A, Frisoni GB; Alzheimer’s Disease Neuroimaging Initiative.

J Neurol. 2019 Oct;266(10):2535-2545. doi: 10.1007/s00415-019-09441-7. Epub 2019 Jul 2.

PMID:
31267207
6.

Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease.

Grimmer T, Goldhardt O, Yakushev I, Ortner M, Sorg C, Diehl-Schmid J, Förstl H, Kurz A, Perneczky R, Miners S.

Neurodegener Dis. 2019;19(1):43-50. doi: 10.1159/000500811. Epub 2019 Jul 2.

PMID:
31266021
7.

An augmented reality approach for ADL support in Alzheimer's disease: a crossover trial.

Rohrbach N, Gulde P, Armstrong AR, Hartig L, Abdelrazeq A, Schröder S, Neuse J, Grimmer T, Diehl-Schmid J, Hermsdörfer J.

J Neuroeng Rehabil. 2019 Jun 3;16(1):66. doi: 10.1186/s12984-019-0530-z.

8.

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia.

Meeter LHH, Steketee RME, Salkovic D, Vos ME, Grossman M, McMillan CT, Irwin DJ, Boxer AL, Rojas JC, Olney NT, Karydas A, Miller BL, Pijnenburg YAL, Barkhof F, Sánchez-Valle R, Lladó A, Borrego-Ecija S, Diehl-Schmid J, Grimmer T, Goldhardt O, Santillo AF, Hansson O, Vestberg S, Borroni B, Padovani A, Galimberti D, Scarpini E, Rohrer JD, Woollacott IOC, Synofzik M, Wilke C, de Mendonca A, Vandenberghe R, Benussi L, Ghidoni R, Binetti G, Niessen WJ, Papma JM, Seelaar H, Jiskoot LC, de Jong FJ, Donker Kaat L, Del Campo M, Teunissen CE, Bron EE, Van den Berg E, Van Swieten JC.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):997-1004. doi: 10.1136/jnnp-2018-319784. Epub 2019 May 23.

9.

Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia.

Alexopoulos P, Thierjung N, Economou P, Werle L, Buhl F, Kagerbauer S, Papanastasiou AD, Grimmer T, Gourzis P, Berthele A, Hemmer B, Kübler H, Martin J, Politis A, Perneczky R.

J Alzheimers Dis. 2019;69(1):83-90. doi: 10.3233/JAD-181088.

PMID:
30909232
10.

FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations.

Diehl-Schmid J, Licata A, Goldhardt O, Förstl H, Yakushew I, Otto M, Anderl-Straub S, Beer A, Ludolph AC, Landwehrmeyer GB, Levin J, Danek A, Fliessbach K, Spottke A, Fassbender K, Lyros E, Prudlo J, Krause BJ, Volk A, Edbauer D, Schroeter ML, Drzezga A, Kornhuber J, Lauer M; FTLDc Study Group, Grimmer T.

Transl Psychiatry. 2019 Jan 31;9(1):54. doi: 10.1038/s41398-019-0381-1.

11.

Effective connectivity in the default mode network is distinctively disrupted in Alzheimer's disease-A simultaneous resting-state FDG-PET/fMRI study.

Scherr M, Utz L, Tahmasian M, Pasquini L, Grothe MJ, Rauschecker JP, Grimmer T, Drzezga A, Sorg C, Riedl V.

Hum Brain Mapp. 2019 Jan 30. doi: 10.1002/hbm.24517. [Epub ahead of print]

PMID:
30697878
12.

Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.

Oeckl P, Halbgebauer S, Anderl-Straub S, Steinacker P, Huss AM, Neugebauer H, von Arnim CAF, Diehl-Schmid J, Grimmer T, Kornhuber J, Lewczuk P, Danek A; Consortium for Frontotemporal Lobar Degeneration German, Ludolph AC, Otto M.

J Alzheimers Dis. 2019;67(2):481-488. doi: 10.3233/JAD-180325.

PMID:
30594925
13.

Correction: 18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases.

Grimmer T, Shi K, Diehl-Schmid J, Natale B, Drzezga A, Förster S, Förstl H, Schwaiger M, Yakushev I, Wester HJ, Kurz A, Yousefi BH.

Mol Psychiatry. 2018 Nov 21. doi: 10.1038/s41380-018-0302-3. [Epub ahead of print]

PMID:
30464328
14.

Functional Decline in Alzheimer's Disease: A Continuum.

Grimmer T, Licata A.

J Am Geriatr Soc. 2018 Dec;66(12):2239-2240. doi: 10.1111/jgs.15668. Epub 2018 Nov 21. No abstract available.

PMID:
30462834
15.

Rate of β-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials.

Guo T, Dukart J, Brendel M, Rominger A, Grimmer T, Yakushev I; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2018 Nov;14(11):1387-1396. doi: 10.1016/j.jalz.2018.05.013. Epub 2018 Jul 4.

PMID:
30420035
16.

A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia.

Nazem A, Tang CC, Spetsieris P, Dresel C, Gordon ML, Diehl-Schmid J, Grimmer T, Yakushev I, Mattis PJ, Ma Y, Dhawan V, Eidelberg D.

Alzheimers Dement (Amst). 2018 Aug 29;10:583-594. doi: 10.1016/j.dadm.2018.07.009. eCollection 2018.

17.

Cognitive Impairment is Associated with Mortality in Hemodialysis Patients.

Angermann S, Schier J, Baumann M, Steubl D, Hauser C, Lorenz G, Günthner R, Braunisch MC, Kemmner S, Satanovskij R, Haller B, Heemann U, Lehnert T, Bieber R, Pachmann M, Braun J, Scherf J, Schätzle G, Fischereder M, Grimmer T, Schmaderer C.

J Alzheimers Dis. 2018;66(4):1529-1537. doi: 10.3233/JAD-180767.

PMID:
30412499
18.

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study.

Scheltens P, Hallikainen M, Grimmer T, Duning T, Gouw AA, Teunissen CE, Wink AM, Maruff P, Harrison J, van Baal CM, Bruins S, Lues I, Prins ND.

Alzheimers Res Ther. 2018 Oct 12;10(1):107. doi: 10.1186/s13195-018-0431-6.

19.

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.

Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, Fox NC, Sanchez-Valle R, Grau-Rivera O, Gelpi E, Seelaar H, Papma JM, van Swieten JC, Hodges JR, Leyton CE, Piguet O, Rogalski EJ, Mesulam MM, Koric L, Nora K, Pariente J, Dickerson B, Mackenzie IR, Hsiung GR, Belliard S, Irwin DJ, Wolk DA, Grossman M, Jones M, Harris J, Mann D, Snowden JS, Chrem-Mendez P, Calandri IL, Amengual AA, Miguet-Alfonsi C, Magnin E, Magnani G, Santangelo R, Deramecourt V, Pasquier F, Mattsson N, Nilsson C, Hansson O, Keith J, Masellis M, Black SE, Matías-Guiu JA, Cabrera-Martin MN, Paquet C, Dumurgier J, Teichmann M, Sarazin M, Bottlaender M, Dubois B, Rowe CC, Villemagne VL, Vandenberghe R, Granadillo E, Teng E, Mendez M, Meyer PT, Frings L, Lleó A, Blesa R, Fortea J, Seo SW, Diehl-Schmid J, Grimmer T, Frederiksen KS, Sánchez-Juan P, Chételat G, Jansen W, Bouchard RW, Laforce RJ, Visser PJ, Ossenkoppele R.

Ann Neurol. 2018 Nov;84(5):729-740. doi: 10.1002/ana.25333.

20.

Serum neurofilament light chain in behavioral variant frontotemporal dementia.

Steinacker P, Anderl-Straub S, Diehl-Schmid J, Semler E, Uttner I, von Arnim CAF, Barthel H, Danek A, Fassbender K, Fliessbach K, Foerstl H, Grimmer T, Huppertz HJ, Jahn H, Kassubek J, Kornhuber J, Landwehrmeyer B, Lauer M, Maler JM, Mayer B, Oeckl P, Prudlo J, Schneider A, Volk AE, Wiltfang J, Schroeter ML, Ludolph AC, Otto M; FTLDc study group.

Neurology. 2018 Oct 9;91(15):e1390-e1401. doi: 10.1212/WNL.0000000000006318. Epub 2018 Sep 12.

PMID:
30209235
21.

Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain Volumetry.

Hedderich DM, Spiro JE, Goldhardt O, Kaesmacher J, Wiestler B, Yakushev I, Zimmer C, Boeckh-Behrens T, Grimmer T.

J Alzheimers Dis. 2018;65(4):1459-1467. doi: 10.3233/JAD-180532.

PMID:
30175976
22.

An Explorative Note on Apraxia Tests.

Gulde P, Leippold K, Armstrong A, Kohl S, Grimmer T, Diehl-Schmid J, Hermsdörfer J.

Front Neurol. 2018 Aug 8;9:660. doi: 10.3389/fneur.2018.00660. eCollection 2018.

23.

18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases.

Grimmer T, Shi K, Diehl-Schmid J, Natale B, Drzezga A, Förster S, Förstl H, Schwaiger M, Yakushev I, Wester HJ, Kurz A, Yousefi BH.

Mol Psychiatry. 2018 Aug 17. doi: 10.1038/s41380-018-0203-5. [Epub ahead of print] Erratum in: Mol Psychiatry. 2018 Nov 21;:.

PMID:
30120417
24.

A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease.

Hartl D, May P, Gu W, Mayhaus M, Pichler S, Spaniol C, Glaab E, Bobbili DR, Antony P, Koegelsberger S, Kurz A, Grimmer T, Morgan K, Vardarajan BN, Reitz C, Hardy J, Bras J, Guerreiro R, Balling R, Schneider JG, Riemenschneider M; AESG.

Mol Psychiatry. 2018 Jul 9. doi: 10.1038/s41380-018-0091-8. [Epub ahead of print]

PMID:
29988083
25.

Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer's Disease.

Alexopoulos P, Thierjung N, Grimmer T, Ortner M, Economou P, Assimakopoulos K, Gourzis P, Politis A, Perneczky R; The Alzheimer’s Disease Neuroimaging Initiative.

Dement Geriatr Cogn Disord. 2018;45(3-4):152-161. doi: 10.1159/000488481. Epub 2018 May 22.

26.

Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach.

Begcevic I, Brinc D, Brown M, Martinez-Morillo E, Goldhardt O, Grimmer T, Magdolen V, Batruch I, Diamandis EP.

J Proteomics. 2018 Jun 30;182:12-20. doi: 10.1016/j.jprot.2018.04.027. Epub 2018 Apr 22.

PMID:
29684683
27.

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleo A, Molinuevo JL, Jagust WJ, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimalla R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon MJ, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R.

Alzheimers Dement. 2018 Jul;14(7):913-924. doi: 10.1016/j.jalz.2018.02.009. Epub 2018 Mar 28.

PMID:
29601787
28.

Step by Step: Kinematics of the Reciprocal Trail Making Task Predict Slowness of Activities of Daily Living Performance in Alzheimer's Disease.

Gulde P, Leippold K, Kohl S, Grimmer T, Diehl-Schmid J, Armstrong A, Hermsdörfer J.

Front Neurol. 2018 Mar 14;9:140. doi: 10.3389/fneur.2018.00140. eCollection 2018.

29.

Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer's disease.

Göttler J, Preibisch C, Riederer I, Pasquini L, Alexopoulos P, Bohn KP, Yakushev I, Beller E, Kaczmarz S, Zimmer C, Grimmer T, Drzezga A, Sorg C.

J Cereb Blood Flow Metab. 2019 Jul;39(7):1314-1325. doi: 10.1177/0271678X18759182. Epub 2018 Feb 12.

PMID:
29431005
30.

Sex Differences in Neuropsychological Test Performance in Alzheimer's Disease and the Influence of the ApoE Genotype.

Tensil M, Hessler JB, Gutsmiedl M, Riedl L, Grimmer T, Diehl-Schmid J.

Alzheimer Dis Assoc Disord. 2018 Apr-Jun;32(2):145-149. doi: 10.1097/WAD.0000000000000229.

PMID:
29189302
31.

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H.

JAMA Psychiatry. 2018 Jan 1;75(1):84-95. doi: 10.1001/jamapsychiatry.2017.3391. Erratum in: JAMA Psychiatry. 2018 Mar 1;75(3):303.

32.

Fluid biomarker agreement and interrelation in dementia due to Alzheimer's disease.

Alexopoulos P, Roesler J, Werle L, Thierjung N, Lentzari I, Ortner M, Grimmer T, Laskaris N, Politis A, Gourzis P, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

J Neural Transm (Vienna). 2018 Feb;125(2):193-201. doi: 10.1007/s00702-017-1810-z. Epub 2017 Nov 15.

PMID:
29143217
33.

Altered neurovascular coupling as measured by optical imaging: a biomarker for Alzheimer's disease.

Kotliar K, Hauser C, Ortner M, Muggenthaler C, Diehl-Schmid J, Angermann S, Hapfelmeier A, Schmaderer C, Grimmer T.

Sci Rep. 2017 Oct 10;7(1):12906. doi: 10.1038/s41598-017-13349-5.

34.

Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening.

Angermann S, Baumann M, Steubl D, Lorenz G, Hauser C, Suttmann Y, Reichelt AL, Satanovskij R, Sonntag F, Heemann U, Grimmer T, Schmaderer C.

PLoS One. 2017 Oct 10;12(10):e0184589. doi: 10.1371/journal.pone.0184589. eCollection 2017.

35.

Resting-State Connectivity of the Left Frontal Cortex to the Default Mode and Dorsal Attention Network Supports Reserve in Mild Cognitive Impairment.

Franzmeier N, Göttler J, Grimmer T, Drzezga A, Áraque-Caballero MA, Simon-Vermot L, Taylor ANW, Bürger K, Catak C, Janowitz D, Müller C, Duering M, Sorg C, Ewers M.

Front Aging Neurosci. 2017 Aug 7;9:264. doi: 10.3389/fnagi.2017.00264. eCollection 2017.

36.

Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease.

Alexopoulos P, Gleixner LS, Werle L, Buhl F, Thierjung N, Giourou E, Kagerbauer SM, Gourzis P, Kübler H, Grimmer T, Yakushev I, Martin J, Kurz A, Perneczky R.

Eur Arch Psychiatry Clin Neurosci. 2018 Aug;268(5):519-524. doi: 10.1007/s00406-017-0815-9. Epub 2017 Jun 10.

PMID:
28602012
37.

Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).

Nave S, Doody RS, Boada M, Grimmer T, Savola JM, Delmar P, Pauly-Evers M, Nikolcheva T, Czech C, Borroni E, Ricci B, Dukart J, Mannino M, Carey T, Moran E, Gilaberte I, Muelhardt NM, Gerlach I, Santarelli L, Ostrowitzki S, Fontoura P.

J Alzheimers Dis. 2017;58(4):1217-1228. doi: 10.3233/JAD-161309.

38.

Pulse wave velocity is associated with cognitive impairment in hemodialysis patients.

Angermann S, Baumann M, Wassertheurer S, Mayer CC, Steubl D, Hauser C, Suttmann Y, Reichelt AL, Satanovskij R, Lorenz G, Lukas M, Haller B, Heemann U, Grimmer T, Schmaderer C.

Clin Sci (Lond). 2017 Jun 28;131(13):1483-1493. doi: 10.1042/CS20170087. Print 2017 Jul 1.

PMID:
28495909
39.

Individual Correspondence of Amyloid-β and Intrinsic Connectivity in the Posterior Default Mode Network Across Stages of Alzheimer's Disease.

Pasquini L, Benson G, Grothe MJ, Utz L, Myers NE, Yakushev I, Grimmer T, Scherr M, Sorg C; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;58(3):763-773. doi: 10.3233/JAD-170096.

PMID:
28482640
40.

Simultaneous object perception deficits are related to reduced visual processing speed in amnestic mild cognitive impairment.

Ruiz-Rizzo AL, Bublak P, Redel P, Grimmer T, Müller HJ, Sorg C, Finke K.

Neurobiol Aging. 2017 Jul;55:132-142. doi: 10.1016/j.neurobiolaging.2017.03.029. Epub 2017 Apr 4.

PMID:
28438484
41.

The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study.

Bosco P, Redolfi A, Bocchetta M, Ferrari C, Mega A, Galluzzi S, Austin M, Chincarini A, Collins DL, Duchesne S, Maréchal B, Roche A, Sensi F, Wolz R, Alegret M, Assal F, Balasa M, Bastin C, Bougea A, Emek-Savaş DD, Engelborghs S, Grimmer T, Grosu G, Kramberger MG, Lawlor B, Mandic Stojmenovic G, Marinescu M, Mecocci P, Molinuevo JL, Morais R, Niemantsverdriet E, Nobili F, Ntovas K, O'Dwyer S, Paraskevas GP, Pelini L, Picco A, Salmon E, Santana I, Sotolongo-Grau O, Spiru L, Stefanova E, Popovic KS, Tsolaki M, Yener GG, Zekry D, Frisoni GB.

Alzheimers Dement. 2017 Sep;13(9):1013-1023. doi: 10.1016/j.jalz.2017.01.019. Epub 2017 Mar 3.

PMID:
28263741
42.

Resting-State Networks as Simultaneously Measured with Functional MRI and PET.

Savio A, Fünger S, Tahmasian M, Rachakonda S, Manoliu A, Sorg C, Grimmer T, Calhoun V, Drzezga A, Riedl V, Yakushev I.

J Nucl Med. 2017 Aug;58(8):1314-1317. doi: 10.2967/jnumed.116.185835. Epub 2017 Mar 2.

43.

Predicting primary progressive aphasias with support vector machine approaches in structural MRI data.

Bisenius S, Mueller K, Diehl-Schmid J, Fassbender K, Grimmer T, Jessen F, Kassubek J, Kornhuber J, Landwehrmeyer B, Ludolph A, Schneider A, Anderl-Straub S, Stuke K, Danek A, Otto M, Schroeter ML; FTLDc study group.

Neuroimage Clin. 2017 Feb 6;14:334-343. doi: 10.1016/j.nicl.2017.02.003. eCollection 2017.

44.

Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI.

Teipel SJ, Wohlert A, Metzger C, Grimmer T, Sorg C, Ewers M, Meisenzahl E, Klöppel S, Borchardt V, Grothe MJ, Walter M, Dyrba M.

Neuroimage Clin. 2017 Jan 18;14:183-194. doi: 10.1016/j.nicl.2017.01.018. eCollection 2017.

45.

Robust Detection of Impaired Resting State Functional Connectivity Networks in Alzheimer's Disease Using Elastic Net Regularized Regression.

Teipel SJ, Grothe MJ, Metzger CD, Grimmer T, Sorg C, Ewers M, Franzmeier N, Meisenzahl E, Klöppel S, Borchardt V, Walter M, Dyrba M.

Front Aging Neurosci. 2017 Jan 4;8:318. doi: 10.3389/fnagi.2016.00318. eCollection 2016.

46.

Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET.

Guo T, Brendel M, Grimmer T, Rominger A, Yakushev I; Alzheimer’s Disease Neuroimaging Initiative.

J Nucl Med. 2017 Apr;58(4):639-645. doi: 10.2967/jnumed.116.176115. Epub 2016 Oct 6.

47.

Neuro-cognitive mechanisms of simultanagnosia in patients with posterior cortical atrophy.

Neitzel J, Ortner M, Haupt M, Redel P, Grimmer T, Yakushev I, Drzezga A, Bublak P, Preul C, Sorg C, Finke K.

Brain. 2016 Dec;139(Pt 12):3267-3280. Epub 2016 Oct 3.

PMID:
27702740
48.

Progressively Disrupted Intrinsic Functional Connectivity of Basolateral Amygdala in Very Early Alzheimer's Disease.

Ortner M, Pasquini L, Barat M, Alexopoulos P, Grimmer T, Förster S, Diehl-Schmid J, Kurz A, Förstl H, Zimmer C, Wohlschläger A, Sorg C, Peters H.

Front Neurol. 2016 Sep 19;7:132. eCollection 2016.

49.

Behavioral variant frontotemporal dementia: advanced disease stages and death. A step to palliative care.

Diehl-Schmid J, Richard-Devantoy S, Grimmer T, Förstl H, Jox R.

Int J Geriatr Psychiatry. 2017 Aug;32(8):876-881. doi: 10.1002/gps.4540. Epub 2016 Jul 4.

PMID:
27374872
50.

The Whole-Brain "Global" Signal from Resting State fMRI as a Potential Biomarker of Quantitative State Changes in Glucose Metabolism.

Thompson GJ, Riedl V, Grimmer T, Drzezga A, Herman P, Hyder F.

Brain Connect. 2016 Jul;6(6):435-47. doi: 10.1089/brain.2015.0394. Epub 2016 May 2.

Supplemental Content

Loading ...
Support Center